NCT01306292View on ClinicalTrials.gov

Safety of SonoVue on Pulmonary Hemodynamics

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Pulmonary Hypertension
Interventions
DRUG

SonoVue

dose of 4.8 mL administered intravenously one time

DRUG

Placebo

Placebo is normal saline 0.9% for injection used as the comparator administered at 4.8 mL (same dose as SonoVue)

Trial Locations (1)

07666

Holy Name Medical Center, Teaneck

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY